Alzamend Neuro Inc.

NASDAQ: ALZN · Real-Time Price · USD
2.38
-0.05 (-2.06%)
At close: Aug 15, 2025, 3:59 PM
2.41
1.26%
After-hours: Aug 15, 2025, 07:41 PM EDT

Alzamend Neuro Cash Flow Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Apr 30, 2025 Apr 30, 2024 Apr 30, 2023 Apr 30, 2022 Apr 30, 2021
Net Income
-4.51M -9.95M -14.88M -12.36M -5.05M
Depreciation & Amortization
50.74K 50.74K 23.07K 3.55K n/a
Stock-Based Compensation
325.11K 955.63K 3.58M 4.41M 2.03M
Other Working Capital
-2.44M 670.67K -1.71M 633.6K -152.45K
Other Non-Cash Items
9.29K 714.00 1.71M 8.77K 454.63K
Deferred Income Tax
n/a n/a -1.71M n/a n/a
Change in Working Capital
-2.44M 670.67K 2.35M 1.33M -152.45K
Operating Cash Flow
-6.57M -8.27M -8.92M -6.61M -2.71M
Capital Expenditures
-300K -147.24K n/a -106.46K n/a
Cash Acquisitions
n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a 5.37M n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a -5.37M 100.92K
Investing Cash Flow
-300K -147.24K n/a -106.46K 100.92K
Debt Repayment
n/a 300K n/a n/a 400.19K
Common Stock Repurchased
n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
600.00 n/a 200.00 18.85M 4.05M
Financial Cash Flow
10.44M 3.65M 200.00 18.85M 4.45M
Net Cash Flow
3.57M -4.76M -8.92M 12.13M 1.84M
Free Cash Flow
-6.87M -8.42M -8.92M -6.72M -2.71M